CureOmics

Business Services · United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

United States

Revenue

<$5 Million

Industry

Business Services Manufacturing Pharmaceuticals Research & Development Health & Nutrition Products Cosmetics, Beauty Supply & Personal Care Products
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About CureOmics

CureOmics is dedicated to transforming health care through innovative life science solutions, focusing on the development of pharmaceuticals, nutraceuticals, and cosmeceuticals. Their research specializes in regenerative medicine and aging biology, addressing health issues such as inflammation, metabolism, and gut health. The company actively partners with other pharmaceutical firms to co-develop drugs and enhance their product offerings. CureOmics aims to improve therapeutic options and preventive care, while also setting new standards in anti-aging skincare solutions.Explore more
Popular SearchesCureOmicsSIC Code 87,873NAICS Code 54,541Show more

Is CureOmics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to CureOmics

Compare insights from companies similar to CureOmics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

CureOmics

<$5M
11-50
Private
-
-
N/A
$9.4M
11-50
Private
<$5M
2014
KH
Karen HanleyExecutive Director, Business Development
$6.3M
11-50
Private
<$5M
2007
PB
Pamela BaxterDirector, Quality
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
2014
JH
Jared HeimovitzManager, Business Development & Marketing
<$5M
1-10
Private
-
-
LW
Lian WangVice President, Translational Sciences
<$5M
1-10
Private
-
2013
N/A
Illustration of an envelope

CureOmics Tech Stack

A closer look at the technologies used by CureOmics

Top Business Services Companies

Frequently Asked Questions Regarding CureOmics

What is CureOmics's official website?
CureOmics's official website is www.cureomics.com
What is CureOmics's Revenue?
CureOmics's revenue is <$5 Million
What is CureOmics's SIC code?
CureOmics's SIC: 87,873
What is CureOmics's NAICS code?
CureOmics's NAICS: 54,541
How many employees does CureOmics have?
CureOmics has 11-50 employees
What industry does CureOmics belong to?
CureOmics is in the industry of: Business Services, Manufacturing, Pharmaceuticals
What is CureOmics competition?
CureOmics top competitors include: CMC Pharmaceuticals, Velesco Pharmaceutical Services, Pharmacin, Dow Development Laboratories
What technology does CureOmics use?
Some of the popular technologies that CureOmics uses are: Sentry, F5 BIG-IP Platform, Sectigo, The USERTRUST Network
What does CureOmics do?

CureOmics is dedicated to transforming health care through innovative life science solutions, focusing on the development of pharmaceuticals, nutraceuticals, and cosmeceuticals. Their research specializes in regenerative medicine and aging biology, addressing health issues such as inflammation, metabolism, and gut health. The company actively partn... ers with other pharmaceutical firms to co-develop drugs and enhance their product offerings. CureOmics aims to improve therapeutic options and preventive care, while also setting new standards in anti-aging skincare solutions.Read More

Is CureOmics a public company?
CureOmics is private company therefore does not currently have an official ticker symbol
See more information about CureOmics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.